- Adults (18-64 years)
- Elderly (≥65 years)
- Community
- Arbovirus
- Chikungunya virus
- Vector-borne
- Arboviral disease
- Vector-borne disease
- Post-acute infection syndrome
Setting: Community
A research environment where studies are conducted outside of clinical or laboratory settings, focusing on real-world populations
- Adults (18-64 years)
- Elderly (≥65 years)
- Community
- Arbovirus
- Chikungunya virus
- Vector-borne
- Arboviral disease
- Vector-borne disease
- Post-acute infection syndrome
- Adults (18-64 years)
- General population
- Outpatient clinic
- Community
- Primary care
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- vasodilator
- Vericiguat
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Community
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Hydrotherapy
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Community
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Community
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
- Stimulation
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Community
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Dietary
- Psychotherapy
- Adults (18-64 years)
- General population
- Adolescents (12-17 years)
- Children (1-11 years)
- Community
- SARS-CoV-2
- Post-COVID-19
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Community
- SARS-CoV-2
- Post-COVID-19
- Adults (18-64 years)
- Elderly (≥65 years)
- Adolescents (12-17 years)
- Children (1-11 years)
- Community
- SARS-CoV-2
- Post-COVID-19
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Community
- SARS-CoV-2
- Post-COVID-19
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Community
- SARS-CoV-2
- Post-COVID-19